I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI ...

Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...

Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

TV star and comedian Katherine Ryan has responded to claims from her teenage daughter that she has been using controversial ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

I am 5 weeks into Mounjaro, the weekly injectable medication that contains Tirzepatide, an active ingredient that supresses and regulates your appetite. Ozempic is perhaps the more famous ...

“[Friday’s] decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA approved Wegovy for cardiovascular disease risk reduction early in ...